Mission
PROVIDING ANTI-RETROVIRALS TO ELIGIBLE HIV VACCINE TRIALS NETWORK PARTICIPANTS.
Based in SEATTLE, WA, Seattle Vaccine Research Fund operates as a Public Charity. The organization reported $122K in revenue, $2.9M in total assets for fiscal year 2025.
PROVIDING ANTI-RETROVIRALS TO ELIGIBLE HIV VACCINE TRIALS NETWORK PARTICIPANTS.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $122K | — | $2.9M |
| 2024 | $131K | — | $2.8M |
| 2023 | $89K | $3K | $2.6M |
| 2022 | $6K | $225K | $2.5M |
Between 2022 and 2025, reported annual revenue grew from $6K to $122K (+2120%), with total assets most recently reported at $2.9M.
Interactive year-over-year charts and full filing details available with membership.